Literature DB >> 6095732

Infection of neuronal cell cultures with reovirus mimics in vitro patterns of neurotropism.

M A Dichter, H L Weiner.   

Abstract

Primary neuronal cell cultures of rat fetal cerebral cortex serve as in vitro models for the study of a variety of neuronal membrane receptors. Such studies have focused primarily on receptors for neurotransmitters and drugs. In the present series of experiments, we have employed this model to study the in vitro pattern of infection with reovirus types 1 and 3, two well-characterized neurotropic viruses that show specificity for neurons (type 3) or ependymal cells (type 1) in vivo and whose specificity has been linked with surface receptors on somatic cells. We have found that in primary neural cell culture, reovirus type 3 maintained its specificity by infecting neurons whereas reovirus type 1 did not infect neurons. Both serotypes infected astrocytes in the cultures, type 1 to a greater extent than type 3. In addition, reovirus type 3 bound to the surface of neurons whereas type 1 did not. Using recombinant viral clones, the in vitro tropism and the neuronal binding were shown to be properties of the viral hemagglutinin, a small outer capsid viral protein, as is the case with the neurotropism in vivo. It is postulated that the neurotropism of reovirus type 3 is related to the interaction of the viral hemagglutinin with an as yet undefined structure on the neuronal surface.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6095732     DOI: 10.1002/ana.410160512

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  29 in total

Review 1.  Reovirus receptors and pathogenesis.

Authors:  J Craig Forrest; Terence S Dermody
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

2.  Identification of the viral genes responsible for growth of strains of reovirus in cultured mouse heart cells.

Authors:  Y Matoba; B Sherry; B N Fields; T W Smith
Journal:  J Clin Invest       Date:  1991-05       Impact factor: 14.808

3.  Ligand binding to the cell surface receptor for reovirus type 3 stimulates galactocerebroside expression by developing oligodendrocytes.

Authors:  J A Cohen; W V Williams; D B Weiner; H M Geller; M I Greene
Journal:  Proc Natl Acad Sci U S A       Date:  1990-07       Impact factor: 11.205

4.  Anti-reovirus receptor antibody accelerates expression of the optic nerve oligodendrocyte developmental program.

Authors:  J A Cohen; W V Williams; H M Geller; M I Greene
Journal:  Proc Natl Acad Sci U S A       Date:  1991-02-15       Impact factor: 11.205

Review 5.  Mechanisms of reovirus bloodstream dissemination.

Authors:  Karl W Boehme; Caroline M Lai; Terence S Dermody
Journal:  Adv Virus Res       Date:  2013       Impact factor: 9.937

6.  Mutations in type 3 reovirus that determine binding to sialic acid are contained in the fibrous tail domain of viral attachment protein sigma1.

Authors:  J D Chappell; V L Gunn; J D Wetzel; G S Baer; T S Dermody
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

7.  Structure of the reovirus cell-attachment protein: a model for the domain organization of sigma 1.

Authors:  M L Nibert; T S Dermody; B N Fields
Journal:  J Virol       Date:  1990-06       Impact factor: 5.103

8.  Optimum length and flexibility of reovirus attachment protein σ1 are required for efficient viral infection.

Authors:  Magdalena Bokiej; Kristen M Ogden; Mine Ikizler; Dirk M Reiter; Thilo Stehle; Terence S Dermody
Journal:  J Virol       Date:  2012-07-18       Impact factor: 5.103

9.  The Nogo receptor NgR1 mediates infection by mammalian reovirus.

Authors:  Jennifer L Konopka-Anstadt; Bernardo A Mainou; Danica M Sutherland; Yuichi Sekine; Stephen M Strittmatter; Terence S Dermody
Journal:  Cell Host Microbe       Date:  2014-06-11       Impact factor: 21.023

10.  Utilization of sialylated glycans as coreceptors enhances the neurovirulence of serotype 3 reovirus.

Authors:  Johnna M Frierson; Andrea J Pruijssers; Jennifer L Konopka; Dirk M Reiter; Ty W Abel; Thilo Stehle; Terence S Dermody
Journal:  J Virol       Date:  2012-10-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.